Hainan Poly Pharm
FDA Approved Drugs

Hainan Poly Pharm

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified
  • Total Records 12
  • Latest Approval Date Nov 14, 2025
  • Data Source FDA
  • First Approval Date Mar 20, 2018
All
12
View
Unclassified
1
View
RX
11
View
Company Overview

Company

Hainan Poly Pharm

Country

China

Social Profiles

Company Snapshot

Hainan Poly Pharm

Guilingyang Economic Development Area, Haikou, Hainan 571127

China

www.hnpoly.com/en/ peterjing@hnpoly.com View on Map
FDA Approved Drug Records ( 12 records )
2022
18 Aug
RX Application: 215890

Drug Name

DAPTOMYCIN

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2022-08-18

215890 / 1

Active Ingredient

DAPTOMYCIN

Application Number

215890

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2022-08-18

Regulatory Status

RX

2023
15 Mar
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

1

Dosage Form

-

Strength

4.5354GM/7.5ML (604.72MG/ML)

Approval Date

2023-03-15

217480 / 1

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

1

Dosage Form

-

Strength

4.5354GM/7.5ML (604.72MG/ML)

Approval Date

2023-03-15

Regulatory Status

RX

2023
15 Mar
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

2

Dosage Form

-

Strength

9.0708GM/15ML (604.72MG/ML)

Approval Date

2023-03-15

217480 / 2

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

2

Dosage Form

-

Strength

9.0708GM/15ML (604.72MG/ML)

Approval Date

2023-03-15

Regulatory Status

RX

2025
16 Apr
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

3

Dosage Form

-

Strength

1.20944GM/2ML (604.72MG/ML)

Approval Date

2025-04-16

217480 / 3

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

3

Dosage Form

-

Strength

1.20944GM/2ML (604.72MG/ML)

Approval Date

2025-04-16

Regulatory Status

RX

2025
16 Apr
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

4

Dosage Form

-

Strength

6.0472GM/10ML (604.72MG/ML)

Approval Date

2025-04-16

217480 / 4

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

4

Dosage Form

-

Strength

6.0472GM/10ML (604.72MG/ML)

Approval Date

2025-04-16

Regulatory Status

RX

2025
16 Apr
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

5

Dosage Form

-

Strength

18.1416GM/30ML (604.72MG/ML)

Approval Date

2025-04-16

217480 / 5

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

5

Dosage Form

-

Strength

18.1416GM/30ML (604.72MG/ML)

Approval Date

2025-04-16

Regulatory Status

RX

2025
16 Apr
RX Application: 217480

Drug Name

GADOBUTROL

Product Number

6

Dosage Form

-

Strength

39.3068GM/65ML (604.72MG/ML)

Approval Date

2025-04-16

217480 / 6

Active Ingredient

GADOBUTROL

Application Number

217480

Product Number

6

Dosage Form

-

Strength

39.3068GM/65ML (604.72MG/ML)

Approval Date

2025-04-16

Regulatory Status

RX

2018
20 Mar
RX Application: 209781

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2018-03-20

209781 / 1

Active Ingredient

LEVETIRACETAM

Application Number

209781

Product Number

1

Dosage Form

-

Strength

500MG/5ML (100MG/ML)

Approval Date

2018-03-20

Regulatory Status

RX

2023
22 May
RX Application: 217314

Drug Name

LEVOLEUCOVORIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)

Approval Date

2023-05-22

217314 / 1

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

217314

Product Number

1

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)

Approval Date

2023-05-22

Regulatory Status

RX

2023
22 May
RX Application: 217314

Drug Name

LEVOLEUCOVORIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML)

Approval Date

2023-05-22

217314 / 2

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

217314

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML)

Approval Date

2023-05-22

Regulatory Status

RX

-
Unclassified Application: 217709

Drug Name

POSACONAZOLE

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

-

217709 / 1

Active Ingredient

POSACONAZOLE

Application Number

217709

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

-

Regulatory Status

Unclassified

2025
14 Nov
RX Application: 220043

Drug Name

VORICONAZOLE

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2025-11-14

220043 / 1

Active Ingredient

VORICONAZOLE

Application Number

220043

Product Number

1

Dosage Form

-

Strength

200MG/20ML (10MG/ML)

Approval Date

2025-11-14

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    8 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    12 View
Drug Status Breakdown
12 total
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

DAPTOMYCIN

Application Number

215890

Product Number

1

Active Ingredient

DAPTOMYCIN

Dosage Form

-

Strength

500MG/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.